| BCBS Texas Medical Policies | Functional Neuromuscular Electrical Stimulation | 2025-08-01 |
| Aetna | Magnetic Resonance Neurography | 2025-08-01 |
| Aetna | Metabolic and Environmental Profiling and Imaging for Kidney Stone Risk | 2025-08-01 |
| Aetna | Hyperhydrosis | 2025-08-01 |
| UHC UMR Medical and Drug | Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions and Soft Tissue Wounds - Commercial and Individual Exchange Medical Policy | 2025-08-01 |
| UHC UMR Medical and Drug | Genetic Testing for Neuromuscular Disorders - Commercial and Individual Exchange Medical Policy | 2025-08-01 |
| UHC UMR Medical and Drug | Home Health, Skilled, and Custodial Care Services (for Commercial Only) - Commercial and Individual Exchange Medical Policy | 2025-08-01 |
| UHC UMR Medical and Drug | Kebilidi™ (Eladocagene Exuparvovec-Tneq) – Commercial Medical Benefit Drug Policy | 2025-08-01 |
| UHC UMR Medical and Drug | Left Atrial Appendage Closure (Occlusion) - Commercial and Individual Exchange Medical Policy | 2025-08-01 |
| UHC UMR Medical and Drug | Off-Label/Unproven Specialty Drug Treatment - Commercial Medical Benefit Drug Policy | 2025-08-01 |